Quality Measures / MVPs / M1420
MVP ID M1420 Supported for 2026
Complete Ophthalmologic Care
For ophthalmology, optometry, NPs and PAs.
17 quality measures we calculate and submit 7 eCQMs and 10 MIPS CQMs 7 outcome measures
Quality measures in this MVP
Report 4, including at least 1 outcome measure. We help you pick the 4 that score best for your clinicians.
| Quality ID | Collection type | Measure | Type | Telehealth |
|---|---|---|---|---|
| 12 | eCQM CMS143v14 | Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation | Process | No |
| 19 | eCQM CMS142v14 | Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care | Process | No |
| 117 | eCQM CMS131v14 | Diabetes: Eye Exam | Process | Yes |
| 130 | eCQM CMS68v15 | Documentation of Current Medications in the Medical Record | Process | Yes |
| 141 | MIPS CQM | Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 20% OR Documentation of a Plan of Care. | Outcome | No |
| 191 | eCQM CMS133v14 | Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery | Outcome | No |
| 226 | eCQM CMS138v14 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | Process | Yes |
| 303 | MIPS CQM | Cataracts: Improvement in Patient’s Visual Function within 90 Days Following Cataract Surgery | Outcome | No |
| 304 | MIPS CQM | Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery | Process | No |
| 374 | eCQM CMS50v14 | Closing the Referral Loop: Receipt of Specialist Report | Process | Yes |
| 384 | MIPS CQM | Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery | Outcome | No |
| 385 | MIPS CQM | Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery | Outcome | No |
| 389 | MIPS CQM | Cataract Surgery: Difference Between Planned and Final Refraction | Outcome | No |
| 499 | MIPS CQM | Appropriate Screening and Plan of Care for Elevated Intraocular Pressure Following Intravitreal or Periocular Steroid Therapy | Process | No |
| 500 | MIPS CQM | Acute Posterior Vitreous Detachment Appropriate Examination and Follow-up | Process | No |
| 501 | MIPS CQM | Acute Posterior Vitreous Detachment and Acute Vitreous Hemorrhage Appropriate Examination and Follow-up | Process | No |
| 503 | MIPS CQM | Gains in Patient Activation Measure (PAM®) Scores at 12 Months | Outcome | Yes |
In this MVP, CMS also lists 6 QCDR measures owned by other registries (IRIS13, IRIS2, IRIS39, IRIS54, IRIS58 and IRIS61). We don’t submit those. Measure list: CMS 2026 MVP specifications (QPP measures data).
The rest of your MVP report
Improvement Activities
Pick 1 of the 12 activities CMS lists for this MVP. Choose it in our registry’s user interface. We generate the output and submit it to CMS electronically with your MVP.
Cost
Cataract Removal with Intraocular Lens (IOL) Implantation (COST_IOL_1). CMS calculates it from Medicare claims, so there is nothing to submit.
Promoting Interoperability
We submit your Promoting Interoperability measures with the MVP. CMS scores the population health measures from claims, so there is nothing else to send.
MVP reporting
+ $100 per clinician, per year
MVP reporting is an add-on to Qualified Registry submission ($300 per clinician, per year, which covers quality, Promoting Interoperability and Improvement Activities). Your final price depends on clinician count.
